Patents-Review.com
ClassID:

170477 ⎘

G01N2333/70503 - CPC Classification

Classification description:

Assays involving biological materials from specific organisms or of a specific nature from animals; from humans; Assays involving receptors, cell surface antigens or cell surface determinants Immunoglobulin superfamily, e.g. VCAMs, PECAM, LFA-3

Sub-classes:
Recent Application in this class:
#1
20260132217
2026-05-14

ANTI-sCD146 ANTIBODIES AND USES THEREOF

 #2
20260131017
2026-05-14

CD22 ANTIBODY AND DRUG CONJUGATES AND USES THEREOF

 #3
20260126440
2026-05-07

METHODS FOR MEASURING LYMPHOCYTE ACTIVITY

 #4
20260085362
2026-03-26

NEUROENDOCRINE CARCINOMA DETECTION AND TREATMENT

 #5
20260053851
2026-02-26

INDUCIBLE SYSTEMS FOR ALTERING GENE EXPRESSION IN HYPOIMMUNOGENIC CELLS

 #6
20260043805
2026-02-12

COMPOSITIONS AND METHODS FOR PLASMAPHERESIS

 #7
20260043804
2026-02-12

COMPOSITIONS AND METHODS FOR PLASMAPHERESIS

 #8
20260042837
2026-02-12

ANTI-TREM2 ANTIBODIES AND RELATED METHODS

 #9
20260041674
2026-02-12

METHODS AND COMPOSITIONS FOR MODULATING THE ACTIVITY OF A DIMERIZING AGENT REGULATED IMMUNOMODULATORY COMPLEX

 #10
20260035460
2026-02-05

COMBINATION THERAPY WITH ANTI-PVRIG ANTIBODIES FORMULATIONS AND ANTI-PD-1 ANTIBODIES

 #11
20260034081
2026-02-05

COMPOSITIONS AND METHODS RELATED TO INHIBITION OF ADENOMAS AND ADENOCARCINOMAS

 #12
20260018250
2026-01-15

COMPUTATIONAL GENERATION OF ARTIFICIAL PROTEINS WITH PROGRAMMABLE IMMUNOGENICITY

 #13
20260015418
2026-01-15

ANTI-ROR1 ANTIBODY, BISPECIFIC ANTIBODY COMPRISING SAME, AND USES THEREOF

 #14
20260009802
2026-01-08

BIOMARKERS

 #15
20260002943
2026-01-01

BIOMARKERS FOR DIAGNOSING EQUINE ASTHMA

 #16
20260001960
2026-01-01

ANTIBODIES AGAINST SIGNAL-REGULATORY PROTEIN ALPHA AND METHODS OF USE

 #17
20250383352
2025-12-18

COMPOSITIONS AND METHODS FOR PLASMAPHERESIS

 #18
20250383351
2025-12-18

COMPOSITIONS AND METHODS FOR PLASMAPHERESIS

 #19
20250377360
2025-12-11

METHODS FOR DETECTING A CANCER

 #20
20250376521
2025-12-11

Siglec Receptor Checkpoint Inhibitors and Method of Using Them to Inhibit Neoplastic Cell Growth

 #21
20250369982
2025-12-04

METHODS OF DETECTING DDR1 PHOSPHORYLATION

 #22
20250369969
2025-12-04

Assessment of immune cells in the uterine fluid at the time of the embryo transfer

 #23
20250362305
2025-11-27

METHODS FOR DETERMINING ONE OR MORE CRITICAL QUALITY ATTRIBUTES OF CO-FORMULATED ANTIBODIES

 #24
20250361295
2025-11-27

NOVEL ANTI-LILRB4 ANTIBODIES AND USES THEREOF

 #25
20250352579
2025-11-20

ANTI-CD7 NANOBODY, AND DERIVATIVE THEREOF AND USE THEREOF IN TUMOR THERAPY

 #26
20250340636
2025-11-06

ANTIBODIES TARGETING L1CAM AND USES THEREOF

 #27
20250334589
2025-10-30

METHODS FOR THE DETECTION AND QUANTIFICATION OF CIRCULATING ENDOTHELIAL CELLS

 #28
20250334578
2025-10-30

CD123 AND CD200 AS MARKERS FOR THE DIAGNOSIS AND IMMUNE-ERADICATION OF LEUKEMIC STEM CELLS (LSCS)

 #29
20250327805
2025-10-23

ENIGMA AND CDH18 AS COMPANION DIAGNOSTICS FOR CDK4 INHIBITORS

 #30
20250316378
2025-10-09

LIQUID BIOPSY FOR DIAGNOSIS OF EARLY OSTEOARTHRITIS

 #31
20250304721
2025-10-02

METHODS FOR GENERATING HIGH AFFINITY ANTIBODIES AGAINST FENTANYL

 #32
20250295767
2025-09-25

ROR1-SPECIFIC ANTIGEN BINDING MOLECULES

 #33
20250288646
2025-09-18

PHARMACEUTICAL COMPOSITION COMPRISING CDON-IG2 DOMAIN PROTEIN FOR TREATING VASCULAR CALCIFICATION

 #34
20250244326
2025-07-31

BLOOD BIOMARKERS IN LONG-COVID-19

 #35
20250243272
2025-07-31

EPITOPE OF REGULATORY T CELL SURFACE ANTIGEN, AND ANTIBODY SPECIFICALLY BINDING THERETO

 #36
20250231196
2025-07-17

USE OF TREM-1 FOR PREDICTING AND PREVENTING POSTOPERATIVE COMPLICATIONS AFTER CARDIAC SURGERY WITH CARDIOPULMONARY BY-PASS

 #37
20250216394
2025-07-03

LIQUID BIOPSY ANALYTES TO DEFINE CANCER STAGES

 #38
20250179175
2025-06-05

ANTI-CD160 TRANSMEMBRANE ISOFORM ANTIBODIES

 #39
20250172557
2025-05-29

METHODS FOR IDENTIFYING LILRB LIGANDS AND BLOCKING ANTIBODIES

 #40
20250136683
2025-05-01

Method of modulating autoimmunity by disrupting cis-ligand binding of siglec type antigens

 #41
20250129431
2025-04-24

METHODS FOR CHARACTERIZATION OF CIRCULATING TUMOR CELLS

 #42
20250123282
2025-04-17

METHODS FOR EVALUATION AND TREATMENT OF TYROSINE KINASE INHIBITOR (TKI)-RESISTANT ACUTE MYELOID LEUKEMIA

 #43
20250115664
2025-04-10

ANTIBODIES AGAINST TIM3 AND USES THEREOF

 #44
20250102521
2025-03-27

INFORMATIVE BIOMARKERS OF PORTAL HYPERTENSION

 #45
20250092130
2025-03-20

COMPOUND THAT SPECIFICALLY BINDS TO KIR3DL2 FOR USE IN THE TREATMENT OF PERIPHERAL T CELL LYMPHOMA

 #46
20250076312
2025-03-06

BIOMARKERS FOR THE TREATMENT OF INTERSTITIAL LUNG DISEASE

 #47
20250060368
2025-02-20

METHODS OF DETECTING AND TREATING IMMUNOTHERAPY-RESISTANT CANCER

 #48
20250052748
2025-02-13

CD83 AND ALLO- AND AUTOIMMUNE CONDITIONS

 #49
20250035617
2025-01-30

Methods for Categorizing and Treating Subjects at Risk for Pulmonary Exacerbation and Disease Progression

 #50
20250032578
2025-01-30

USE OF A PHARMACEUTICAL COMPOSITION

 #51
20250011423
2025-01-09

METHODS TO REVERSE TREML1-INDUCED IMMUNE SUPPRESSION

 #52
20250011421
2025-01-09

ANTIBODY AGAINST HUMAN TIGIT AND USE THEREOF

 #53
20250002577
2025-01-02

LILRB2/1 ANTIBODY PRODUCTS AND METHODS

 #54
20240426810
2024-12-26

ANTI-PD1 THERAPY BASED ON RESPONSE TO IFN-I STIMULATION

 #55
20240425586
2024-12-26

TREATMENT OF PERIPHERAL T CELL LYMPHOMA

 #56
20240410902
2024-12-12

USE OF SOLUBLE TREM2 AS A NON-INVASIVE BIOMARKER FOR NON-ALCOHOLIC STEATOHEPATITIS (NASH)

 #57
20240402172
2024-12-05

Compositions and methods for plasmapheresis

 #58
20240385198
2024-11-21

STING MODULATOR COMPOSITIONS AND METHODS OF USE AND DETECTION THEREOF

 #59
20240352119
2024-10-24

ANTI-ROR1 ANTIBODIES AND USES THEREOF

 #60
20240343798
2024-10-17

COMPOSITIONS AND METHODS FOR TREATING AUTOIMMUNE DISEASES AND CANCERS BY TARGETING IGSF8

 #61
20240329054
2024-10-03

SOLUBLE CD33 AS A BIOMARKER FOR ANTI-CD33 EFFICACY

 #62
20240327512
2024-10-03

COMPOSITIONS AND METHODS FOR TREATMENT OF RETINAL DEGENERATION

 #63
20240319207
2024-09-26

METHOD FOR IDENTIFYING T-CELL EPITOPE SEQUENCE, AND APPLICATION OF SAME

 #64
20240311638
2024-09-19

NATURAL KILLER CELL EFFICACY PREDICTION METHOD AND COMPUTING DEVICE

 #65
20240301055
2024-09-12

CYTOTOXIC ANTI-LAG-3 MONOCLONAL ANTIBODY AND ITS USE IN THE TREATMENT OR PREVENTION OF ORGAN TRANSPLANT REJECTION AND AUTOIMMUNE DISEASE

 #66
20240298619
2024-09-12

NON-HUMAN ANIMALS HAVING A HUMANIZED PROGRAMMED CELL DEATH 1 GENE

 #67
20240294602
2024-09-05

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

 #68
20240285839
2024-08-29

Compositions and methods for plasmapheresis

 #69
20240277911
2024-08-22

Compositions and methods for plasmapheresis

 #70
20240255525
2024-08-01

BIOMARKER FOR IN VITRO DIAGNOSIS AND/OR PROGNOSIS OF A SYSTEMIC INFLAMMATION

 #71
20240247273
2024-07-25

THERAPEUTIC OLIGONUCLEOTIDES

 #72
20240230646
2024-07-11

HIGHLY SENSITIVE AND SPECIFIC LUCIFERASE BASED REPORTER ASSAY FOR ANTIGEN DETECTION

 #73
20240228613
2024-07-11

SINGLE DOMAIN ANTIBODY AGAINST CD47 AND USE THEREOF

 #74
20240218337
2024-07-04

FUSION PROTEIN TARGETING PD-L1 AND NEUTRALIZING GAS6 AND USES THEREOF

 #75
20240210393
2024-06-27

DETECTION AND TREATMENT OF AUTOIMMUNE DISORDERS

 #76
20240180963
2024-06-06

DIAGNOSIS AND TREATMENT OF MYELOID DISORDERS AND ACUTE LEUKEMIAS USING NOVEL TUMOR SPECIFIC ANTIGENS

 #77
20240168025
2024-05-23

HEMATOPOIETIC CELL PHENOTYPING USING CIRCULATING CELL-FREE MARKERS

 #78
20240151726
2024-05-09

DIAGNOSTIC METHODS FOR LIVER DISORDERS

 #79
20240133885
2024-04-25

HIGHLY SENSITIVE AND SPECIFIC LUCIFERASE BASED REPORTER ASSAY FOR ANTIGEN DETECTION

 #80
20240132588
2024-04-25

SINGLE DOMAIN ANTIBODY AGAINST CD47 AND USE THEREOF

 #81
20240103010
2024-03-28

PVRL2 AND/OR PVRIG AS BIOMARKERS FOR TREATMENT

 #82
20240024417
2024-01-25

THERAPEUTIC MODULATION OF ALCAM/CD166

 #83
20240018236
2024-01-18

CD19-TARGETING HUMANIZED ANTIBODY AND USE THEREOF

 #84
20240016936
2024-01-18

USES OF CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL THERAPIES IN COMBINATION WITH INHIBITORS OF INFLAMMATION-RELATED SOLUBLE FACTORS

 #85
20230408524
2023-12-21

Reagent composition for detection of non-hematopoietic tumor and use thereof

 #86
20230408523
2023-12-21

METHODS OF IDENTIFYING GAMMA DELTA T CELL-MODULATING AGENTS

 #87
20230357394
2023-11-09

ANTI-HUMAN LAG-3 ANTIBODIES AND THEIR USE IN IMMUNOHISTOCHEMISTRY (IHC)

 #88
20230348563
2023-11-02

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

 #89
20230333110
2023-10-19

REAGENT COMPOSITION FOR IMMUNOPHENOTYPING OF B LYMPHOBLASTIC LEUKEMIA/LYMPHOMA AND USE THEREOF

 #90
20230333090
2023-10-19

LAG3 ANTAGONIST CELL BASED POTENCY ASSAY

 #91
20230287110
2023-09-14

ANTI-TREM2 ANTIBODIES AND RELATED METHODS

 #92
20230273208
2023-08-31

SOLUBLE TREM-1 AS A MARKER OF SEVERITY OR COMPLICATIONS FOR A SUBJECT SUFFERING FROM A CORONAVIRUS INFECTION

 #93
20230266343
2023-08-24

Methods, Systems & Kits for Prediction, Detection, Monitoring & Treatment of Alzheimer's Disease

 #94
20230265158
2023-08-24

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

 #95
20230235016
2023-07-27

PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

 #96
20230235015
2023-07-27

PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

 #97
20230235014
2023-07-27

PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

 #98
20230203155
2023-06-29

ROR1-SPECIFIC ANTIGEN BINDING MOLECULES

 #99
20230203127
2023-06-29

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

 #100
20230201301
2023-06-29

TREM-1 INHIBITOR FOR USE IN THE TREATMENT OF A SUBJECT SUFFERING FROM A CORONAVIRUS INFECTION

 #101
20230184776
2023-06-15

METHOD OF ISOLATING CIRCULATING TUMOR CELLS

 #102
20230151076
2023-05-18

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

 #103
20230133318
2023-05-04

Biomarkers of membranous glomerulonephritis

 #104
20230113246
2023-04-13

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

 #105
20230088740
2023-03-23

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

 #106
20230087025
2023-03-23

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

 #107
20230077903
2023-03-16

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

 #108
20230074660
2023-03-09

Detection reagent and therapeutic target for B cell tumor after targeted therapy and related application

 #109
20230068235
2023-03-02

Methods for determining and achieving therapeutically effective doses of anti-CD47 agents in treatment of cancer

 #110
20230038044
2023-02-09

COMPANION DIAGNOSIS BIOMARKER COMPOSITION AND COMPANION DIAGNOSIS KIT CONTAINING SAME

 #111
20230033235
2023-02-02

NPTN65 IS A NEW TARGET FOR THE TREATMENT OF TAUOPATHIES

 #112
20230018821
2023-01-19

ANTIBODIES AGAINST SIGNAL-REGULATORY PROTEIN ALPHA AND METHODS OF USE

 #113
20220381795
2022-12-01

Biomarkers and Methods for Measuring and Monitoring Inflammatory Disease Activity

 #114
20220357329
2022-11-10

PREDICTIVE LIQUID MARKERS FOR CANCER IMMUNOTHERAPY

 #115
20220340682
2022-10-27

ANTI-CEACAM5 ANTIBODIES AND USES THEREOF

 #116
20220289847
2022-09-15

METHODS FOR THE TREATMENT OF CANCER

 #117
20220228119
2022-07-21

BROWN ADIPOCYTE PROGENITORS IN HUMAN SKELETAL MUSCLE

 #118
20220213168
2022-07-07

Peptides and combination of peptides for use in immunotherapy against various tumors

 #119
20220206012
2022-06-30

METHODS FOR DETERMINING DIFFERENCES IN ALPHA-4 INTEGRIN ACTIVITY BY CORRELATING DIFFERENCES IN sVCAM AND/OR sMAdCAM LEVELS

 #120
20220205987
2022-06-30

Methods for categorizing and treating subjects having cystic fibrosis (CF) and at risk for severe pulmonary exacerbation

 #121
20220187311
2022-06-16

METHODS FOR THE DETECTION AND QUANTIFICATION OF CIRCULATING ENDOTHELIAL CELLS

 #122
20220169722
2022-06-02

Anti-lag-3 antibody polypeptide

 #123
20220144944
2022-05-12

LILRB4-binding antibody and methods of use thereof

 #124
20220144917
2022-05-12

STABILIZED EXTRACELLULAR DOMAIN OF CD19

 #125
20220137072
2022-05-05

MARKERS AND THEIR USE IN BRAIN INJURY

 #126
20220135685
2022-05-05

TREATMENT OF PD-L1-NEGATIVE MELANOMA USING AN ANTI-PD-1 ANTIBODY AND AN ANTI-CTLA-4 ANTIBODY

 #127
20220135677
2022-05-05

ANTI-SIRP ALPHA ANTIBODIES

 #128
20220135671
2022-05-05

ANTI-SIRP ALPHA ANTIBODIES

 #129
20220135642
2022-05-05

CELLS, COMPOSITIONS AND METHODS FOR ENHANCING IMMUNE FUNCTION

 #130
20220098253
2022-03-31

Lipocalin muteins with binding affinity for LAG-3

 #131
20220089720
2022-03-24

Antibodies against TIM3 and uses thereof

 #132
20220073919
2022-03-10

THERAPEUTIC OLIGONUCLEOTIDES

 #133
20220041690
2022-02-10

Peptides and combination of peptides for use in immunotherapy against various tumors

 #134
20220041689
2022-02-10

Peptides and combination of peptides for use in immunotherapy against various tumors

 #135
20220033469
2022-02-03

Peptides and combination of peptides for use in immunotherapy against various tumors

 #136
20220018844
2022-01-20

Method for treating a cancer based on inflammatory subtype thereof

 #137
20220017598
2022-01-20

Peptides and combination of peptides for use in immunotherapy against various tumors

 #138
20220017595
2022-01-20

Peptides and combination of peptides for use in immunotherapy against various tumors

 #139
20220009995
2022-01-13

Peptides and combination of peptides for use in immunotherapy against various tumors

 #140
20220002378
2022-01-06

Peptides and combination of peptides for use in immunotherapy against various tumors

 #141
20210403530
2021-12-30

Peptides and combination of peptides for use in immunotherapy against various tumors

 #142
20210396767
2021-12-23

Method for Predicting Prognosis of Ischemic Disease

 #143
20210395338
2021-12-23

Peptides and combination of peptides for use in immunotherapy against various tumors

 #144
20210395337
2021-12-23

Peptides and combination of peptides for use in immunotherapy against various tumors

 #145
20210395336
2021-12-23

Peptides and combination of peptides for use in immunotherapy against various tumors

 #146
20210395335
2021-12-23

Peptides and combination of peptides for use in immunotherapy against various tumors

 #147
20210395334
2021-12-23

Peptides and combination of peptides for use in immunotherapy against various tumors

 #148
20210382073
2021-12-09

COMPOSITIONS AND METHODS FOR IDENTIFYING SUBJECTS AT RISK FOR TRAUMATIC BRAIN INJURY

 #149
20210380688
2021-12-09

ANTIBODIES FOR TREATING MALIGNANT TUMORS AND USES THEREOF

 #150
20210371520
2021-12-02

Anti-human LAG-3 antibodies and their use in immunohistochemistry (IHC)

 #151
20210363269
2021-11-25

Antibodies against signal-regulatory protein alpha and methods of use

 #152
20210363248
2021-11-25

Compound that specifically binds to KIR3DL2 for use in the treatment of peripheral T cell lymphoma

 #153
20210363246
2021-11-25

Fusion proteins comprising extracellular domain of human CD22

 #154
20210355213
2021-11-18

TREATMENT OF T CELL LYMPHOMA

 #155
20210325394
2021-10-21

METHOD FOR PROVIDING INFORMATION ON THERAPEUTIC REACTION OF CANCER IMMUNOTHERAPY AND KIT USING SAME

 #156
20210317210
2021-10-14

CYTOTOXIC ANTI-LAG-3 MONOCLONAL ANTIBODY AND ITS USE IN THE TREATMENT OR PREVENTION OF ORGAN TRANSPLANT REJECTION AND AUTOIMMUNE DISEASE

 #157
20210317204
2021-10-14

BI-SPECIFIC BINDING MOLECULES

 #158
20210285964
2021-09-16

Atypical hemolytic uremic syndrome (AHUS) biomarker proteins

 #159
20210269521
2021-09-02

BISPECIFIC ANTIBODY AND USE THEREOF

 #160
20210230273
2021-07-29

Humanized anti-CD200 antibodies and uses thereof

 #161
20210223267
2021-07-22

METHODS AND DEVICES FOR DETECTING DIABETIC NEPHROPATHY AND ASSOCIATED DISORDERS

 #162
20210214807
2021-07-15

METHOD AND KIT FOR THE DIAGNOSIS OF COLORECTAL CANCER

 #163
20210188944
2021-06-24

Peptides and combination of peptides for use in immunotherapy against various tumors

 #164
20210188943
2021-06-24

Peptides and combination of peptides for use in immunotherapy against various tumors

 #165
20210179691
2021-06-17

Peptides and combination of peptides for use in immunotherapy against various tumors

 #166
20210163590
2021-06-03

Anti-TIM-3 antibodies

 #167
20210155689
2021-05-27

Anti-human LAG-3 monoclonal antibody and use thereof

 #168
20210148931
2021-05-20

Compositions and methods for predicting post-surgical cardiovascular events

 #169
20210147540
2021-05-20

Anti-ROR1 antibodies and uses thereof

 #170
20210080461
2021-03-18

Method of therapy selection for patient suffering from glioblastoma

 #171
20210047412
2021-02-18

Canine antibody therapeutic for treating cancer

 #172
20210032330
2021-02-04

Anti-TIM-3 antibodies and uses thereof

 #173
20210017280
2021-01-21

Constructs trageting CD22 and uses thereof

 #174
20210003575
2021-01-07

Use of BMMFI Rep protein as biomarker for colorectal cancer

 #175
20200400682
2020-12-24

Biomarkers and Methods for Measuring and Monitoring Inflammatory Disease Activity

 #176
20200400672
2020-12-24

Reagents and Methods for Breast Cancer Detection

 #177
20200363411
2020-11-19

Methods of Detecting Alloantibodies Using HLA and Non-HLA Antigens

 #178
20200347353
2020-11-05

Brown adipocyte progenitors in human skeletal muscle

 #179
20200325206
2020-10-15

Peptides and combination of peptides for use in immunotherapy against various tumors

 #180
20200308250
2020-10-01

Peptides and combination of peptides for use in immunotherapy against various tumors

 #181
20200277606
2020-09-03

Therapeutic oligonucleotides

 #182
20200277398
2020-09-03

Humanized antibodies against CEACAM1

 #183
20200256859
2020-08-13

Methods for Categorizing and Treating Subjects at Risk for Pulmonary Exacerbation and Disease Progression

 #184
20200255516
2020-08-13

TIGIT antibody, antigen-binding fragment thereof, and medical use thereof

 #185
20200216557
2020-07-09

Polynucleotides encoding humanized antibodies against CEACAM1

 #186
20200209237
2020-07-02

Detection and treatment of autoimmune disorders

 #187
20200199228
2020-06-25

KIR3DL2 binding agents

 #188
20200182886
2020-06-11

Methods for detecting sinusoidal obstructive syndrome (SOS)

 #189
20200181259
2020-06-11

Anti-CD47 antibodies and uses thereof

 #190
20200155680
2020-05-21

IMMUNE MODULATORS IN COMBINATION WITH RADIATION TREATMENT

 #191
20200140546
2020-05-07

Anti-TREM2 antibodies and related methods

 #192
20200138980
2020-05-07

METHODS AND COMPOSITIONS FOR THE DETECTION OF CANCER

 #193
20200110100
2020-04-09

MARKERS AND THEIR USE IN BRAIN INJURY

 #194
20200102401
2020-04-02

Anti-CEACAM5 antibodies and uses thereof

 #195
20200095644
2020-03-26

Methods for identification, assessment, prevention, and treatment of cancer using PD-L1 isoforms

 #196
20200087378
2020-03-19

Relaxin1 derived peptides for use in immunotherapy

 #197
20200079851
2020-03-12

Anti-LILRB antibodies and their use in detecting and treating cancer

 #198
20200057070
2020-02-20

DIAGNOSTIC METHODS FOR LIVER DISORDERS

 #199
20200055916
2020-02-20

Soluble CD33 for treating myelodysplastic syndromes (MDS)

 #200
20200053992
2020-02-20

Non-human animals having a humanized programmed cell death 1 gene

 #201
20200048317
2020-02-13

Human tear lipocalin muteins which specifically bind lymphocyte activation gene-3 (LAG3) and method of use thereof to stimulate an immune response

 #202
20200040060
2020-02-06

Peptides and combination of peptides for use in immunotherapy against various tumors

 #203
20200031899
2020-01-30

Peptides and combination of peptides for use in immunotherapy against various tumors

 #204
20200024325
2020-01-23

Peptides and combination of peptides for use in immunotherapy against various tumors

 #205
20200016144
2020-01-16

Method for assessing the efficacy of IMiDs and composition or combination for use in treating IMiD sensitive diseases

 #206
20190365855
2019-12-05

Use of recombinant lymphocyte activation gene-3 as a companion therapeutic for patients at risk for cardiovascular disease and other chronic inflammatory diseases

 #207
20190345207
2019-11-14

Lipocalin muteins with binding affinity for LAG-3

 #208
20190330700
2019-10-31

Molecular Profiling of Immune Modulators

 #209
20190324038
2019-10-24

Methods for the identification, targeting and isolation of human dendritic cell (DC) precursors “pre-DC” and their uses thereof

 #210
20190315857
2019-10-17

Treatment of peripheral T cell lymphoma

 #211
20190310261
2019-10-10

NOVEL TARGET FOR ANTI-CANCER AND IMMUNE-ENHANCING

 #212
20190310259
2019-10-10

Enigma and CDH18 as companion diagnostics for CDK4 inhibitors

 #213
20190309064
2019-10-10

Anti-TREM2 antibodies and related methods

 #214
20190300595
2019-10-03

Peptides and combination of peptides for use in immunotherapy against various tumors

 #215
20190285647
2019-09-19

SRM/MRM Assays For CD56 And CHGA Proteins

 #216
20190194328
2019-06-27

TREATMENT OF PD-L1-NEGATIVE MELANOMA USING AN ANTI-PD-1 ANTIBODY AND AN ANTI-CTLA-4 ANTIBODY

 #217
20190185540
2019-06-20

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

 #218
20190162728
2019-05-30

Methods and materials for treating renal cell carcinoma

 #219
20190145975
2019-05-16

Method to identify antigen-specific immune cells

 #220
20190128878
2019-05-02

Methods for categorizing and treating subjects at risk for pulmonary exacerbation and disease progression

 #221
20190127463
2019-05-02

Compound that specifically binds to KIR3DL2 for use in the treatment of peripheral T cell lymphoma

 #222
20190119352
2019-04-25

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

 #223
20190119351
2019-04-25

Peptides and combination of peptides for use in immunotherapy against various tumors

 #224
20190107542
2019-04-11

Method of isolating circulating tumor cells

 #225
20190107537
2019-04-11

Highly sensitive and specific luciferase based reporter assay for antigen detection

 #226
20190106491
2019-04-11

Methods for determining and achieving therapeutically effective doses of anti-CD47 agents in treatment of cancer

 #227
20190101547
2019-04-04

COMPOSITIONS AND METHODS FOR IDENTIFYING SUBJECTS AT RISK FOR TRAUMATIC BRAIN INJURY

 #228
20190064170
2019-02-28

Hematopoietic cell phenotyping using circulating cell-free markers

 #229
20190056397
2019-02-21

Diagnostic assays and methods of treating pneumonia, sepsis and systemic inflammatory response syndrome

 #230
20190040132
2019-02-07

Anti-ROR1 antibodies and uses thereof

 #231
20190031729
2019-01-31

Muteins of human tear lipocalin capable of binding lymphocyte-activation gene 3 (LAG-3) and methods of use thereof

 #232
20190024180
2019-01-24

Method and kit for the diagnosis of colorectal cancer

 #233
20190023762
2019-01-24

Peptides and combination of peptides for use in immunotherapy against various tumors

 #234
20190011466
2019-01-10

Method for diagnosing disseminated intravascular coagulation (DIC)

 #235
20190002569
2019-01-03

Methods and pharmaceutical compositions for the treatment of diseases mediated by the NRP-1/OBR complex signaling pathway

 #236
20190002524
2019-01-03

Peptides and combination of peptides for use in immunotherapy against various tumors

 #237
20180356427
2018-12-13

Regulatory T-cells, method for their isolation and uses

 #238
20180356419
2018-12-13

BIOMARKERS FOR DETECTION OF TUBERCULOSIS RISK

 #239
20180356403
2018-12-13

Use of immune repertoire diversity for predicting transplant rejection

 #240
20180346548
2018-12-06

Peptides and combination of peptides for use in immunotherapy against various tumors

 #241
20180340019
2018-11-29

Peptides and combination of peptides for use in immunotherapy against various tumors

 #242
20180327475
2018-11-15

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

 #243
20180319883
2018-11-08

Anti SIRP-α antibodies and bi-specific macrophage enhancing antibodies

 #244
20180312587
2018-11-01

Anti-SIRPα antibodies

 #245
20180275129
2018-09-27

Reagents and Methods for Breast Cancer Detection

 #246
20180259540
2018-09-13

Biomarkers for seizures

 #247
20180258155
2018-09-13

RELAXIN1 derived peptides for use in immunotherapy against various tumors

 #248
20180251518
2018-09-06

Peptides and combination of peptides for use in immunotherapy against various tumors

 #249
20180251517
2018-09-06

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

 #250
20180246114
2018-08-30

IDENTIFICATION OF PROTEIN ASSOCIATED WITH HEPATOCELLULAR CARCINOMA, GLIOBASTOMA AND LUNG CANCER

 #251
20180238907
2018-08-23

MARKERS AND THEIR USE IN BRAIN INJURY

 #252
20180238905
2018-08-23

METHODS AND COMPOSITIONS FOR DIAGNOSIS OF ECTOPIC PREGNANCY

 #253
20180238895
2018-08-23

ANTIBODIES RECOGNIZING A CARBOHYDRATE CONTAINING EPITOPE ON CD-43 AND CEA EXPRESSED ON CANCER CELLS AND METHODS USING SAME

 #254
20180237494
2018-08-23

Peptides and combination of peptides for use in immunotherapy against various tumors

 #255
20180237493
2018-08-23

Peptides and combination of peptides for use in immunotherapy against various tumors

 #256
20180230195
2018-08-16

Peptides and combination of peptides for use in immunotherapy against various tumors

 #257
20180230194
2018-08-16

Peptides and combination of peptides for use in immunotherapy against various tumors

 #258
20180224465
2018-08-09

Endothelial cell derived exosomes and uses thereof

 #259
20180208641
2018-07-26

Peptides and combination of peptides for use in immunotherapy against various tumors

 #260
20180208640
2018-07-26

Peptides and combination of peptides for use in immunotherapy against various tumors

 #261
20180206462
2018-07-26

NON-HUMAN ANIMALS HAVING A HUMANIZED PROGRAMMED CELL DEATH 1 GENE

 #262
20180201680
2018-07-19

Single agent anti-PD-L1 and PD-L2 dual binding antibodies and methods of use

 #263
20180201676
2018-07-19

METHODS AND COMPOSITIONS FOR MODULATING LILR PROTEINS

 #264
20180188251
2018-07-05

SRM/MRM assays for cancer

 #265
20180177847
2018-06-28

COMPOSITIONS AND METHODS FOR MODULATING PRO-INFLAMMATORY IMMUNE RESPONSE

 #266
20180171337
2018-06-21

Therapeutic oligonucleotides

 #267
20180164329
2018-06-14

Prostate cancer-associated secreted proteins

 #268
20180164282
2018-06-14

Methods of diagnosing infection or recurrence in a subject

 #269
20180141993
2018-05-24

Peptides and combination of peptides for use in immunotherapy against various tumors

 #270
20180105600
2018-04-19

Antibodies against signal-regulatory protein alpha and methods of use

 #271
20180100005
2018-04-12

Peptides and combination of peptides for use in immunotherapy against various tumors

 #272
20180094043
2018-04-05

Peptides and combination of peptides for use in immunotherapy against various tumors

 #273
20180086830
2018-03-29

Antibody molecules to LAG-3 and uses thereof

 #274
20180086829
2018-03-29

Anti-LILRB antibodies and their use in detecting and treating cancer

 #275
20180067134
2018-03-08

Erythrocyte-derived extracellular vesicles as a biomarker for clinically assessing Parkinson's disease

 #276
20180052162
2018-02-22

METHOD TO DETECT THE ONSET AND TO MONITOR THE RECURRENCE OF CHRONIC GRAFT VERSUS HOST DISEASE IN TRANPLANTATION PATIENTS

 #277
20180037629
2018-02-08

Peptides and combination of peptides for use in immunotherapy against various tumors

 #278
20180037628
2018-02-08

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

 #279
20180037627
2018-02-08

Peptides and combination of peptides for use in immunotherapy against various tumors

 #280
20180037626
2018-02-08

Peptides and combination of peptides for use in immunotherapy against various tumors

 #281
20180030113
2018-02-01

Peptides and combination of peptides for use in immunotherapy against various tumors

 #282
20180022817
2018-01-25

Anti-CEACAM5 antibodies and uses thereof

 #283
20180016338
2018-01-18

ANTI CEACAM1 ANTIBODIES AND METHODS OF USING SAME

 #284
20170370947
2017-12-28

Methods and Devices for Detecting Diabetic Nephropathy and Associated Disorders

 #285
20170370934
2017-12-28

METHODS AND COMPOSITIONS FOR IMMUNOMODULATION

 #286
20170370933
2017-12-28

METHODS AND COMPOSITIONS FOR IMMUNOMODULATION

 #287
20170360932
2017-12-21

IMMUNE MODULATORS IN COMBINATION WITH RADIATION TREATMENT

 #288
20170343565
2017-11-30

Biomarkers for seizures

 #289
20170328887
2017-11-16

Method for assessing therapeutic effect of anti-cancer agent having anti-CD4 antibody as active ingredient

 #290
20170327894
2017-11-16

Combination method for treating cancer by targeting immunoglobulin superfamily member 1 (IGSF1) and mesenchymal-epithelial transition factor (MET)

 #291
20170327591
2017-11-16

Diagnosis and treatment of cancer expressing ILT3 or ILT3 ligand

 #292
20170313760
2017-11-02

Peptides and combination of peptides for use in immunotherapy against various tumors

 #293
20170312338
2017-11-02

Use of recombinant lymphocyte activation gene-3 as a companion therapeutic for patients at risk for cardiovascular disease and other chronic inflammatory diseases

 #294
20170307617
2017-10-26

Methods and materials for treating renal cell carcinoma

 #295
20170305993
2017-10-26

Peptides and combination of peptides for use in immunotherapy against various tumors

 #296
20170305992
2017-10-26

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

 #297
20170298132
2017-10-19

Compound that specifically binds to KIR3DL2 for use in the treatment of peripheral T cell lymphoma

 #298
20170296524
2017-10-19

Method for assessing the efficacy of IMiDs and composition or combination for use in treating IMiD sensitive diseases

 #299
20170281569
2017-10-05

METHOD FOR ENHANCING IMMUNE CELL FUNCTION AND METHOD FOR ASSESSING IMMUNE CELL MULTIFUNCTIONALITY

 #300
20170269102
2017-09-21

ATYPICAL HEMOLYTIC UREMIC SYNDROME (AHUS) BIOMARKER PROTEINS